Non-Muscle Invasive Bladder Urothelial Carcinoma Clinical Trials
2 recruiting trials for Non-Muscle Invasive Bladder Urothelial Carcinoma. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT06770582
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy...
This phase II trial compares the use of pembrolizumab and radiation therapy to chemotherapy with cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C and radiation therapy for...
Sponsor: National Cancer Institute (NCI)Enrolling: 16020 locations
RECRUITINGPhase 4NCT05962541
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder...
Background: In European Association of Urology (EAU) Guidelines, the vast majority of non-muscle-invasive bladder cancers (NMIBCs) undergo a primary transurethral resection of the...
Sponsor: University of Roma La SapienzaEnrolling: 3271 location